4-Amino-3-fluorobenzoic Acid: A Key Intermediate for Pharma Manufacturers
In the intricate world of pharmaceutical manufacturing, the selection of high-quality intermediates is paramount to the success of drug development and production. Among the versatile building blocks available, 4-Amino-3-fluorobenzoic acid (CAS 455-87-8) stands out due to its unique chemical structure and broad applicability. As a premier manufacturer in China, we understand the critical needs of pharmaceutical companies seeking reliable and high-purity raw materials. This article delves into why 4-Amino-3-fluorobenzoic acid is an indispensable compound for your synthesis needs.
Understanding 4-Amino-3-fluorobenzoic Acid
4-Amino-3-fluorobenzoic acid is an organic compound characterized by its benzoic acid core, featuring an amino group at the 4th position and a fluorine atom at the 3rd position. Its chemical formula is C7H6FNO2, and it is known for its consistent physical properties, typically appearing as white to light yellow crystals with a melting point in the range of 215-218°C. The presence of both the amine and carboxylic acid functionalities makes it a highly reactive and versatile molecule for various chemical transformations.
Applications in Pharmaceutical Synthesis
The pharmaceutical industry relies heavily on intermediates like 4-Amino-3-fluorobenzoic acid for the synthesis of Active Pharmaceutical Ingredients (APIs). Its structure is particularly well-suited for creating compounds with specific biological activities. For instance, it serves as a key intermediate in the synthesis of anticonvulsant drugs, helping to manage conditions like epilepsy and neuropathic pain. Furthermore, its derivatives are explored for their anti-inflammatory and antitumor properties, making it a valuable component in medicinal chemistry research and drug discovery pipelines. Buying 4-amino-3-fluorobenzoic acid for these applications ensures the foundational quality required for therapeutic efficacy and safety.
Why Choose a Reliable Supplier?
The purity and consistency of chemical intermediates directly impact the yield, quality, and regulatory compliance of final pharmaceutical products. As a dedicated supplier of 4-amino-3-fluorobenzoic acid, we prioritize rigorous quality control and advanced manufacturing processes. Our commitment ensures that every batch meets the high standards expected by the pharmaceutical sector. Sourcing from our facility in China offers the advantage of competitive price points for bulk quantities, without compromising on the critical purity levels (typically ≥98.0%) essential for pharmaceutical synthesis.
Sourcing Strategies for Pharmaceutical Manufacturers
For pharmaceutical manufacturers, securing a dependable supply chain is as crucial as the chemical itself. We offer flexible packaging and support for custom requirements, ensuring seamless integration into your production workflow. Whether you are looking to purchase 4-amino-3-fluorobenzoic acid for research and development or for large-scale manufacturing, our team is equipped to meet your demands. By choosing us as your manufacturer, you gain a strategic partner committed to providing the building blocks for your next breakthrough drug.
In conclusion, 4-Amino-3-fluorobenzoic acid is more than just a chemical; it's a critical enabler for pharmaceutical innovation. Its versatile chemical nature and the assurance of high purity make it a preferred choice for leading drug manufacturers worldwide. Partner with us to secure this essential intermediate and propel your pharmaceutical development forward.
Perspectives & Insights
Core Pioneer 24
“Furthermore, its derivatives are explored for their anti-inflammatory and antitumor properties, making it a valuable component in medicinal chemistry research and drug discovery pipelines.”
Silicon Explorer X
“Buying 4-amino-3-fluorobenzoic acid for these applications ensures the foundational quality required for therapeutic efficacy and safety.”
Quantum Catalyst AI
“The purity and consistency of chemical intermediates directly impact the yield, quality, and regulatory compliance of final pharmaceutical products.”